Company Overview and News
The S&P 500 and Dow Jones industrial average hit all-time highs on Friday, and the Nasdaq was not that far behind. Although talks of tariffs have been abundant this past week it did not take any wind out of the markets’ sails. Coming up this week, there are a few major U.S. companies with quarterly reports that could help push the markets even higher, including the best-performing Dow stock.
JBL KBH KMX RAD CCL CUK CAXPF NKE CUKPF CCL TRI CAG BB BBBY
2018-09-22 seekingalpha - 2
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
TCBK CAT MET HTH LBCC FIXX CRM BUSE STXB CHFC FIBH FBLV AVGO HBMD CAG SSB ABX MO SBT UMRX PRU MTZ NBHC HOMB EVRI 2914 FFIN BILI OPBK TAP ABRW OZK ACB BREW UNUM OLBK MTN JNJ GHG ALDX BWA VZ FNV EQBK LMT FB JAPAF RAD FNLC AXP 4162 ITYBF PRU CBTX JAPAY PPBI SFNC PNFP TBK CCL KO NCOM NBHOZ CARO TSC BOFIL KBH LION SPPI SMBK PACW DY LTEA BB WSBC TTEC VBTX ABCB DTEA HBNC GNPX FBPRM FBPRL FBPRO XLC FBPRN SNDX CSFL FBPRP MBIN HTWC AZN KMX ACBFF GBCI BATS SIVB KEY BOKF ASNA ABTX HTLF NKE HON TWTR AMAT CELH ROX JBL FBP IMBBY BY CHCO KDP INCY CRON FSB CCL STZ NBEV WTFCW WTFC FBMS WTFCM INTU NBHDZ GOOGL EGBN LTXB STL FBNC BA BB ONB PRGS FBK PFE IMBBF PFBC PH NEM LOXO MNST GOOG PIR RBB TLRY HWC PB BFST NCBS MKC WEED ACN FBSI BBBY DIS BMY OBNK OGE MBNC RNST ABX BOFI CMCSA SNV UBSH WTFPP CGC CADE AZN T IBOC IQ ONE MRK GNTY
2018-09-21 zacks - 1
U.S. stocks saw a mostly positive week after Wall Street shrugged off early concerns about escalating trade tensions. Investors are still looking with a cautious eye toward next week’s Fed meeting, but with Q3 earnings season on the horizon, it is possible a thaw in the trade war could give way to further gains.
NKE RAD SPG BB BB EOG
Rite Aid Corporation (RAD - Free Report) is slated to report second-quarter fiscal 2019 results on Sep 27. The big question facing investors is whether this drug store retailer will be able to deliver a positive earnings surprise in the quarter to be reported. In the fiscal first quarter, the company reported loss of 1 cent per share, which lagged the Zacks Consensus Estimate of break-even results.
TSCO AMZN PEP RAD
ABDERDEEN, Md. (AP) — Three people were killed Thursday morning in a shooting at a Rite Aid distribution center in northeast Maryland, officials said.
A shooting Thursday morning at a warehouse near Aberdeen, Md., has resulted in at least three fatalities and multiple injuries, according to several reports. The shooting happened near a Rite-Aid warehouse about 55 miles away from Baltimore, reports say. The Federal Bureau of Investigation described developments as an "active shooter situation" and said its Baltimore field office was assisting in the matter, according to a report from the Chicago Sun Times.
The past year has been tremendous for e-commerce giant Amazon (AMZN - Free Report) . The stock has gained a massive 96.8%, way ahead of the 15.8% rise of the S&P 500 Index. Online media giant Netflix (NFLX - Free Report) has surged 88.7%. Leading pizza delivery company, Domino’s Pizza (DPZ - Free Report) has risen 40.1% over the past year. On the contrary, retail drug store industry majors, Rite Aid (RAD - Free Report) and Walgreens Boots Alliance (WBA - Free Report) have witnessed a steep decline of 52.
HD TGT TXN RAD MDPEB WBA NFLX MDP
2018-09-13 247wallst - 4
August is often a period of summer doldrums in the stock markets. Yet this year, those investors, traders, analysts and others who didn’t go away on holiday saw the markets reclaiming all-time highs (in a record bull run), after an earnings season that was stronger than many expected, as well as an economy that is strong despite growing trade wars and rising interest rates and inflation.
BAC CKRGZ JCP CHKVP RAD DTK CHKDH CHKVZ CHKDG CHKWZ BAC CHKDJ CHKDP CHK CHK.WI
2018-09-12 investorplace - 4
Generally, investors who own widely-held stocks or mega-cap companies can hope to at least match the market’s performance. But beating the market can often require diving into small-cap stocks — stocks whose companies have market caps of $2 billion or less. These smaller companies just have more room to grow.
SONO AMZN JCP CRON RAD AKS
Aetna (NYSE:AET) stock has soared of late, for two key reasons. First, a takeout of Aetna stock by CVS (NYSE:CVS) appears increasingly likely to pass regulatory muster. Secondly, CVS stock, a component of the consideration paid for AET stock, has gained, increasing the value of the offer.
FRED AMZN RAD WBA CVS AET
The vast majority of Amazon Prime members who have health insurance told Deutsche Bank that they would be willing to purchase prescription drugs on the online retailer's website.
BRK.A DB RAD CAH CVS
Rite Aid is in desperate need of management that cares about running the company. There is a slight chance this could include current management, but shareholders are all too aware of the emphasis on selling or merging Rite Aid instead of operating it as a going concern. This focus on mergers is harming present day operations and the 2018 10K lists 10 out of 35 forward looking risks related to past or present merger details.
2017-10-11 - Asif
Rite Aid is a pharmacy retail healthcare company, providing its customers and communities with a high level of care and service through various programs the company offer through its two reportable business segments, its Retail Pharmacy segment and its Pharmacy Services segment. The company accomplish its goal of delivering comprehensive care to its customers through its retail drugstores, RediClinic walk-in retail health clinics and transparent and traditional EnvisionRx and MedTrak PBMs. The company also offer fully integrated mail-order and specialty pharmacy services through EnvisionPharmacies. Additionally through EIC, EnvisionRx also serves one of the fastest-growing demographics in healthcare: seniors enrolled in Medicare Part D. When combined with its retail platform, this comprehensive suite of services allows it to provide value and choice to customers, patients and payors and allows it to succeed in today’s evolving healthcare marketplace. Rite Aid has two reportable bu...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to RAD / Rite Aid Corp. on message board site Silicon Investor.
as of ET